The Women’s Cancer Screening Package includes a selection of laboratory tumor markers that may help assess the risk of certain cancers when interpreted alongside clinical findings and diagnostic imaging. These tests support physicians in the evaluation and monitoring of specific conditions but are not intended to diagnose or rule out cancer on their own. Further medical assessment may be required if abnormal results are detected.
This test measures laboratory biomarkers that may be associated with cancers of the gastrointestinal tract, including the stomach and intestines. Results should always be interpreted together with clinical evaluation and, when appropriate, imaging or endoscopic examinations.
This test evaluates laboratory markers commonly used in the assessment of liver tumors. It may assist healthcare providers in the evaluation and monitoring of liver disease but is not sufficient to diagnose liver cancer by itself.
This blood test measures tumor-associated biomarkers that may support the clinical evaluation and monitoring of breast disease. It does not replace mammography, breast ultrasound, MRI, or routine breast cancer screening.
This test measures biomarkers that may provide additional information during the evaluation of certain gynecological conditions. It is used as an adjunct to clinical assessment and imaging studies when indicated.
This laboratory test evaluates biomarkers that may be associated with pancreatic disease. It may assist physicians during clinical evaluation but should always be interpreted alongside imaging and other diagnostic investigations.
Package Benefits
Supports the assessment of selected tumor markers associated with women’s health.
May assist in the evaluation and monitoring of certain cancers when clinically indicated.
Provides valuable laboratory information to complement medical assessment.
Helps physicians determine whether additional diagnostic investigations are needed.
Suitable for individuals with increased risk factors, relevant symptoms, or those requiring follow-up under medical supervision.
Important Note: Tumor marker tests are screening and monitoring tools and should not be used alone to diagnose cancer. Normal results do not completely exclude the presence of cancer, and abnormal results do not necessarily indicate cancer. Clinical evaluation and appropriate imaging remain essential for an accurate diagnosis
سيتم التواصل معك من قبل وريد لتاكيد الحجز
سيتم التبرع بجزء من قيمة الفاتورة عبر منصة إحسان قدامك العافية
